FSOAX | JVMAX | FSOAX / JVMAX | |
Total Expense Ratio | 1.09 | 1.12 | 97% |
Annual Report Gross Expense Ratio | 1.09 | 1.13 | 96% |
Fund Existence | 29 years | 28 years | - |
Gain YTD | -15.184 | -7.710 | 197% |
Front Load | 6% | 5% | 115% |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.84B | 19.6B | 9% |
Annual Yield % from dividends | 0.89 | 0.61 | 144% |
Returns for 1 year | -18.57 | -10.96 | 169% |
Returns for 3 years | -12.34 | -8.30 | 149% |
Returns for 5 years | 65.59 | 46.80 | 140% |
Returns for 10 years | -7.32 | 19.44 | -38% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.10 | -0.69% |
YieldMax AMZN Option Income Strategy ETF |